Research graph
References from Prevalence, Incidence, and Impact of Cancer in Atrial Fibrillation: A Systematic Review and Meta‐Analysis of 70,000,000 Patients. Local targets link to admitted publications; unresolved targets remain external evidence.
The Clinical Profile and Pathophysiology of Atrial Fibrillation: Relationships Among Clinical Features, Epidemiology, and Mechanisms
10.1161/circresaha.114.303211 · 2014 · External reference
Cognitive Dysfunction in Atrial Fibrillation
10.1038/s41569-018-0075-z · 2018 · External reference
Atrial Fibrillation
10.1016/j.jacc.2020.02.025 · 2020 · External reference
Atrial Fibrillation Prevalence, Awareness and Management in a Nationwide Survey of Adults in China
10.1136/heartjnl-2020-317915 · 2021 · External reference
Causes of Death and Influencing Factors in Patients With Atrial Fibrillation: A Competing‐Risk Analysis From the Randomized Evaluation of Long‐Term Anticoagulant Therapy Study
10.1161/circulationaha.112.000491 · 2013 · External reference
Increased Burden of Comorbidities and Risk of Cardiovascular Death in Atrial Fibrillation Patients in Europe over Ten Years: A Comparison Between EORP‐AF Pilot and EHS‐AF Registries
10.1016/j.ejim.2018.05.016 · 2018 · External reference
Long‐Term Relationship Between Atrial Fibrillation, Multimorbidity and Oral Anticoagulant Drug Use
10.1016/j.mayocp.2019.06.012 · 2019 · External reference
Variations in Common Diseases, Hospital Admissions, and Deaths in Middle‐Aged Adults in 21 Countries From Five Continents (Pure): A Prospective Cohort Study
10.1016/s0140-6736(19)32007-0 · 2020 · External reference
Common Pathophysiology in Cancer, Atrial Fibrillation, Atherosclerosis, and Thrombosis
2021 · External reference
2022 ESC Guidelines on Cardio‐Oncology Developed in Collaboration With the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio‐Oncology Society (IC‐OS)
10.1093/eurheartj/ehac244 · 2022 · External reference
Cancer Increases the Risk of Atrial Fibrillation During Long‐Term Follow‐Up (OPERA Study)
10.1371/journal.pone.0205454 · 2018 · External reference
Incidence of Atrial Fibrillation in Different Major Cancer Subtypes: A Nationwide Population‐Based 12 Year Follow Up Study
10.1186/s12885-019-6314-9 · 2019 · External reference
Atrial Fibrillation as a Marker of Occult Cancer
10.1371/journal.pone.0102861 · 2014 · External reference
Risk of Malignant Cancer Among Women With New‐Onset Atrial Fibrillation
10.1001/jamacardio.2016.0280 · 2016 · External reference
Inflammation and Cancer
10.1038/nature01322 · 2002 · External reference
Obesity and Cancer
10.1634/theoncologist.2009-0285 · 2010 · External reference
Inflammation and the Pathogenesis of Atrial Fibrillation
10.1038/nrcardio.2015.2 · 2015 · External reference
Lifestyle Factors and Risk of Multimorbidity of Cancer and Cardiometabolic Diseases: A Multinational Cohort Study
10.1186/s12916-019-1474-7 · 2020 · External reference
Cardiometabolic‐Based Chronic Disease, Adiposity and Dysglycemia Drivers
10.1016/j.jacc.2019.11.044 · 2020 · External reference
Cancer and Thrombosis: New Insights to An Old Problem
10.1016/s2542-4513(20)30514-9 · 2020 · External reference
Atrial Fibrillation and Cancer—An Unexplored Field in Cardiovascular Oncology
10.1016/j.blre.2019.03.005 · 2019 · External reference
Meta‐Analysis of Observational Studies in Epidemiology. A Proposal for Reporting. Meta‐Analysis Of Observational Studies in Epidemiology (MOOSE) group
10.1001/jama.283.15.2008 · 2000 · External reference
Prisma 2020 Explanation and Elaboration: Updated Guidance and Exemplars for Reporting Systematic Reviews
2021 · External reference
Unresolved reference
External reference
Random Effects Meta‐Analysis of Event Outcome in the Framework of the Generalized Linear Mixed Model With Applications in Sparse Data
10.1002/sim.4040 · 2010 · External reference
Seriously Misleading Results Using Inverse of Freeman‐Tukey Double Arcsine Transformation in Meta‐Analysis of Single Proportions
10.1002/jrsm.1348 · 2019 · External reference
Plea for Routinely Presenting Prediction Intervals in Meta‐Analysis
10.1136/bmjopen-2015-010247 · 2016 · External reference
Interpretation of Random Effects Meta‐Analyses
10.1136/bmj.d549 · 2011 · External reference
Measuring Inconsistency in Meta‐Analyses
10.1136/bmj.327.7414.557 · 2003 · External reference
Trim and Fill: A Simple Funnel‐Plot‐Based Method of Testing and Adjusting for Publication Bias in Meta‐Analysis
10.1111/j.0006-341x.2000.00455.x · 2000 · External reference
Warfarin Use Among Patients With Atrial Fibrillation
10.1161/01.str.28.12.2382 · 1997 · External reference
Combined Anticoagulant‐Antiplatelet Use and Major Bleeding Events in Elderly Atrial Fibrillation Patients
10.1161/01.str.0000141933.75462.c2 · 2004 · External reference
Compliance With Antithrombotic Prescribing Guidelines for Patients With Atrial Fibrillation—A Nationwide Descriptive Study in Taiwan
10.1016/j.clinthera.2008.09.010 · 2008 · External reference
Anticoagulant Use, the Prevalence of Bridging, and Relation to Length of Stay Among Hospitalized Patients With Non‐Valvular Atrial Fibrillation
2012 · External reference
All‐Cause Mortality in 272186 Patients Hospitalized With Incident Atrial Fibrillation 1995‐2008: A Swedish Nationwide Long‐Term Case‐Control Study
10.1093/eurheartj/ehs469 · 2013 · External reference
A Clinical Decision Instrument for 30‐Day Death After An Emergency Department Visit for Atrial Fibrillation: The Atrial Fibrillation in the Emergency Room (AFTER) Study
10.1016/j.annemergmed.2015.07.017 · 2015 · External reference
Cause of Death in Patients With Atrial Fibrillation Admitted to French Hospitals in 2012: A Nationwide Database Study
10.1136/openhrt-2015-000290 · 2015 · External reference
Determinants of Oral Anticoagulation Control in New Warfarin Patients: Analysis Using Data From Clinical Practice Research Datalink
10.1016/j.thromres.2015.06.007 · 2015 · External reference
Therapeutic Management in Ambulatory Elderly Patients With Atrial Fibrillation: The S.AGES Cohort
10.1007/s12603-015-0444-9 · 2015 · External reference
Thirty‐Day Mortality in ED Patients With New Onset Atrial Fibrillation and Actively Treated Cancer
10.1016/j.ajem.2015.07.033 · 2015 · External reference
Warfarin Persistence Among Stroke Patients With Atrial Fibrillation
10.1016/j.thromres.2015.07.028 · 2015 · External reference
Adherence to Antithrombotic Therapy Guidelines Improves Mortality Among Elderly Patients With Atrial Fibrillation: Insights From the REPOSI Study
10.1007/s00392-016-0999-4 · 2016 · External reference
Causes of Death and Influencing Factors in Patients With Atrial Fibrillation
10.1016/j.amjmed.2016.06.045 · 2016 · External reference
Choice of New Oral Anticoagulant Agents Versus Vitamin K Antagonists in Atrial Fibrillation: FANTASIIA Study
10.1177/1074248415596426 · 2016 · External reference
Comparative Effectiveness of Antiarrhythmic Drugs for Rhythm Control of Atrial Fibrillation
10.1016/j.jjcc.2015.07.001 · 2016 · External reference
Cessation of Oral Anticoagulation Is An Important Risk Factor for Stroke and Mortality in Atrial Fibrillation Patients
10.1160/th16-12-0961 · 2017 · External reference
Clinical Significance of Hematuria in Atrial Fibrillation With Oral Anticoagulation Therapy
10.1253/circj.cj-16-0917 · 2017 · External reference
Efficacy and Safety of Apixaban Versus Warfarin in Patients With Atrial Fibrillation and a History of Cancer: Insights From the ARISTOTLE Trial
10.1016/j.amjmed.2017.06.026 · 2017 · External reference
Factors Driving the Use of Warfarin and Non‐Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation
10.1016/j.jfma.2016.05.007 · 2017 · External reference
Major Gastrointestinal Bleeding Often Is Caused by Occult Malignancy in Patients Receiving Warfarin or Dabigatran to Prevent Stroke and Systemic Embolism From Atrial Fibrillation
10.1016/j.cgh.2016.10.011 · 2017 · External reference
Management and Outcomes of Patients With Atrial Fibrillation and a History of Cancer: The ORBIT‐AF Registry
10.1093/ehjqcco/qcx004 · 2017 · External reference
Multimorbidity and the Risk of Hospitalization and Death in Atrial Fibrillation: A Population‐Based Study
10.1016/j.ahj.2016.11.008 · 2017 · External reference
Oral Anticoagulant Use in Octogenarian European Patients With Atrial Fibrillation: A Subanalysis of PREFER in AF
10.1016/j.ijcard.2017.01.046 · 2017 · External reference
Prevalence of Atrial Fibrillation and Antithrombotic Therapy in Hemodialysis Patients: Cross‐Sectional Results of the Vienna InVestigation of Atrial Fibrillation and Thromboembolism in Patients on HemoDIalysis (VIVALDI)
10.1371/journal.pone.0169400 · 2017 · External reference
Bleeding With Oral Anticoagulant Dabigatran Is Highly Associated With Occult Cancers in Atrial Fibrillation Patients
10.2217/fca-2017-0063 · 2018 · External reference
CHA2DS2‐VASC Score and Risk of Thromboembolism and Bleeding in Patients With Atrial Fibrillation and Recent Cancer
10.1177/2047487318759858 · 2018 · External reference
Clinical Characteristics and Thromboembolic Risk of Atrial Fibrillation Patients With and Without Congestive Heart Failure. Results From the CRATF Study
10.1097/md.0000000000013074 · 2018 · External reference
Importance of Considering Competing Risks in Time‐To‐Event Analyses: Application to Stroke Risk in a Retrospective Cohort Study of Elderly Patients With Atrial Fibrillation
2018 · External reference
In‐Hospital Cerebrovascular Outcomes of Patients With Atrial Fibrillation and Cancer (From the National Inpatient Sample Database)
10.1016/j.amjcard.2017.11.027 · 2018 · External reference
Mortality and Causes of Death in Patients With Atrial Fibrillation: A Nationwide Population‐Based Study
10.1371/journal.pone.0209687 · 2018 · External reference
Patients With Cancer and Atrial Fibrillation Treated With Doacs: A Prospective Cohort Study
10.1016/j.ijcard.2018.07.138 · 2018 · External reference
Provider Specialty, Anticoagulation, and Stroke Risk in Patients With Atrial Fibrillation and Cancer
10.1016/j.jacc.2018.07.077 · 2018 · External reference
The Impact of Cancer on Major Bleeding and Stroke/Systemic Emboli in Patients Using Direct Oral Anticoagulants: From the Database of a Single‐Center Registry
10.4022/jafib.2105 · 2018 · External reference
Atrial Fibrillation: A New Indicator for Advanced Colorectal Neoplasia in Screening Colonoscopy
10.3390/jcm8071083 · 2019 · External reference
Bleeding and New‐Onset Cancers in Patients With Atrial Fibrillation Receiving Nonvitamin K Antagonist Oral Anticoagulants
10.1016/j.amjcard.2018.11.046 · 2019 · External reference
Comparative Effectiveness of Rivaroxaban Versus a Vitamin K Antagonist in Patients With Renal Impairment Treated for Non‐Valvular Atrial Fibrillation in Germany—A Retrospective Cohort Study
10.1016/j.ijcha.2019.100367 · 2019 · External reference
Dose Reduction of Non‐Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation: A Danish Nationwide Cohort Study
10.1016/j.thromres.2019.04.007 · 2019 · External reference
Efficacy and Safety of Rivaroxaban Vs. Warfarin in Patients With Non‐Valvular Atrial Fibrillation and a History of Cancer: Observations From ROCKET AF
10.1093/ehjqcco/qcy040 · 2019 · External reference
Safety and Effectiveness of Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation and Anemia: A Retrospective Cohort Study
10.1161/jaha.119.012029 · 2019 · External reference
Thrombocytopenia and Mortality Risk in Patients With Atrial Fibrillation: An Analysis From the START Registry
10.1161/jaha.119.012596 · 2019 · External reference
Utilization of Oral Anticoagulants in Korean Nonvalvular Atrial Fibrillation Patients
10.1007/s11096-019-00901-8 · 2019 · External reference
Association of Multimorbidity With Cardiovascular Endpoints and Treatment Effectiveness in Patients 75 Years and Older With Atrial Fibrillation
10.1016/j.amjmed.2020.03.038 · 2020 · External reference
Cancer‐Specific Ischemic Complications in Elderly Patients With Atrial Fibrillation: Data From the Prospective ATHERO‐AF Study
10.1002/ijc.33179 · 2020 · External reference
Current Anticoagulant Usage Patterns and Determinants in Korean Patients With Nonvalvular Atrial Fibrillation
10.3349/ymj.2020.61.2.120 · 2020 · External reference
Multimorbidity, Physical Frailty, and Self‐Rated Health in Older Patients With Atrial Fibrillation
10.1186/s12877-020-01755-w · 2020 · External reference
Net Benefit of Oral Anticoagulants in Patients With Atrial Fibrillation and Active Cancer: A Nationwide Cohort Study
2020 · External reference
Risk of Ischemic Stroke and Major Bleeding in Patients With Atrial Fibrillation and Cancer
10.1016/j.jstrokecerebrovasdis.2019.104560 · 2020 · External reference
Tailoring Anticoagulant Treatment of Patients With Atrial Fibrillation Using a Novel Bleeding Risk Score
2020 · External reference
The Admit‐AF Risk Score: A Clinical Risk Score for Predicting Hospital Admissions in Patients With Atrial Fibrillation
10.1177/2047487320915350 · 2020 · External reference
Use of Oral Anticoagulants After Ischaemic Stroke in Patients With Atrial Fibrillation and Cancer
10.1111/joim.13092 · 2020 · External reference
Atrial Fibrillation, Oral Anticoagulants, and Concomitant Active Cancer: Benefits and Risks
10.1055/s-0041-1728670 · 2021 · External reference
Clinical Outcomes in Atrial Fibrillation Patients With a History of Cancer Treated With Non‐Vitamin K Antagonist Oral Anticoagulants: A Nationwide Cohort Study
10.1161/strokeaha.120.033470 · 2021 · External reference
Current Status of Oral Anticoagulant Adherence in Japanese Patients With Atrial Fibrillation: A Claims Database Analysis
10.1016/j.jjcc.2021.02.007 · 2021 · External reference
Haematuria and Urinary Tract Cancers in Patients With Atrial Fibrillation Treated With Oral Anticoagulants
10.1093/ehjcvp/pvaa045 · 2021 · External reference
Novel Bleeding Risk Score for Patients With Atrial Fibrillation on Oral Anticoagulants, Including Direct Oral Anticoagulants
10.1111/jth.15251 · 2021 · External reference
Thromboembolism, Mortality, and Bleeding in 2,435,541 Atrial Fibrillation Patients With and Without Cancer: A Nationwide Cohort Study
10.1002/cncr.33470 · 2021 · External reference
Why Did All Patients With Atrial Fibrillation and High Risk of Stroke Not Receive Oral Anticoagulants? Results of the Polish Atrial Fibrillation (pol‐af) Registry
10.3390/jcm10194611 · 2021 · External reference
Association of Sex With Stroke and Bleeding Risk of Apixaban and Rivaroxaban in Elderly Atrial Fibrillation Patients Using Propensity Score Weights
10.1016/j.cjco.2021.09.002 · 2022 · External reference
Clinical Phenotypes of Atrial Fibrillation and Mortality Risk—A Cluster Analysis From the Nationwide Italian START Registry
10.3390/jpm12050785 · 2022 · External reference
Contemporary Survival and Anticoagulation of Patients With Atrial Fibrillation: A Community Based Cohort Study in China
10.3389/fcvm.2022.911393 · 2022 · External reference
Effect of Cancer on Clinical Outcomes in Elderly Patients With Non‐Valvular Atrial Fibrillation—Substudy of the ANAFIE Registry
10.1253/circj.cj-21-0631 · 2022 · External reference
Emergency Department Capacity to Initiate Thromboprophylaxis in Patients With Atrial Fibrillation and Thrombotic Risk After Discharge: URGFAICS Cohort Analysis
10.1007/s11739-021-02864-z · 2022 · External reference
Emergency Department Cardiovascular Disease Encounters and Associated Mortality in Patients With Cancer: A Study of 20.6 Million Records From the USA
External reference
Impact of Malignancy on Outcomes in European Patients With Atrial Fibrillation: A Report From the ESC‐EHRA Eurobservational Research Programme in Atrial Fibrillation General Long‐Term Registry
10.1111/eci.13773 · 2022 · External reference
Outcomes and Discriminatory Accuracy of the CHA2DS2VASc Score in Atrial Fibrillation and Cancer
10.1016/j.jacadv.2023.100609 · 2022 · External reference
Anticoagulant Treatment in Patients With AF and Very High Thromboembolic Risk in the Era before and After the Introduction of NOAC: Observation at a Polish Reference Centre
10.3390/ijerph20126145 · 2023 · External reference
Arterial Thromboembolism in Patients With AF and CHA2DS2‐VASc Score 0‐2 With and Without Cancer
2023 · External reference
Atrial Fibrillation and Chronic Obstructive Pulmonary Disease: Diagnostic Sequence and Mortality Risk
10.1093/ehjqcco/qcac059 · 2023 · External reference
Riesgo Hemorrágico Y Embólico De Los Pacientes Con Fibrilación Auricular Y Cáncer
10.1016/j.recesp.2022.08.021 · 2023 · External reference
Cancer and Atrial Fibrillation Comorbidities Among 25 Million Citizens in Shanghai, China: Medical Insurance Database Study
10.2196/40149 · 2023 · External reference
Clinical Outcomes and Predictors of a Gap in Direct‐Acting Oral Anticoagulant Therapy in the Elderly: A Time‐Varying Analysis of a Nationwide Cohort Study
10.1016/j.thromres.2023.04.018 · 2023 · External reference
Influence of HIV on In‐Hospital Outcomes in Patients With Atrial Fibrillation
10.1080/00015385.2022.2129185 · 2023 · External reference
Integrated Care for Atrial Fibrillation Using the ABC Pathway in the Prospective APHRS‐AF Registry
2023 · External reference
Left Atrial Appendage Closure Outcomes in Patients With Cancer at a Single Tertiary Center
10.1016/j.amjcard.2023.06.068 · 2023 · External reference
Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation and Cancer
2023 · External reference
Risk Factors Associated With Atrial Fibrillation in Elderly Patients
10.14740/jocmr4884 · 2023 · External reference
Utilization and Short‐Term Outcomes of Percutaneous Left Atrial Appendage Occlusion in Patients With Cancer
10.1186/s40959-023-00192-z · 2023 · External reference
Appropriateness of Direct Oral Anticoagulant Prescribing in Older Subjects With Atrial Fibrillation Discharged From Acute Medical Wards
10.1111/bcp.16010 · 2024 · External reference
Association of Atrial Fibrillation With Insomnia in the Elderly Population
10.1177/21501319241296623 · 2024 · External reference
Atrial Fibrillation Catheter Ablation Among Cancer Patients: Utilization Trends and In‐Hospital Outcomes
10.3390/jcm13051318 · 2024 · External reference
Coexisting Atrial Fibrillation and Cancer: Time Trends and Associations With Mortality in a Nationwide Dutch Study
10.1093/eurheartj/ehae222 · 2024 · External reference
Development of a Risk Score for Predicting One‐Year Mortality in Patients With Atrial Fibrillation Using Xgboost‐Assisted Feature Selection
10.33963/v.phj.101842 · 2024 · External reference
Effect of Nutritional Status on Adverse Clinical Events in Elderly Patients With Nonvalvular Atrial Fibrillation: A Retrospective Cohort Study
10.1111/anec.13130 · 2024 · External reference
Impact of Newly Diagnosed Cancer on Bleeding Events in Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants
10.1007/s40256-024-00676-y · 2024 · External reference
In‐Hospital and Readmission Outcomes of Patients With Myeloproliferative Neoplasms and Atrial Fibrillation: Insights From the National Readmissions Database
10.1007/s11239-023-02900-z · 2024 · External reference
Incidence of All‐Cause, Cardiovascular, and Atrial Fibrillation‐Related Hospitalizations: Focus on Antiarrhythmic Drugs
10.1016/j.jacadv.2024.101117 · 2024 · External reference
Ischemic Stroke Temporally Associated With New‐Onset Atrial Fibrillation: A Population‐Based Registry‐Linkage Study
10.1161/strokeaha.123.044448 · 2024 · External reference
Left Atrial Appendage Closure in Atrial Fibrillation Patients With Cancer
10.3390/jcm13216514 · 2024 · External reference
Oral Anticoagulant Prescribing Among Patients With Cancer and Atrial Fibrillation in England, 2009–2019
10.1002/cncr.35152 · 2024 · External reference
Oral Anticoagulation Therapy in Atrial Fibrillation Patients at High Risk of Bleeding: Clinical Characteristics and Treatment Strategies Based on Data From the Polish Multicenter Register of Atrial Fibrillation (POL‐AF)
10.33963/v.kp.98356 · 2024 · External reference
Outcomes of 1.3 Million Patients Undergoing Percutaneous Coronary Intervention According to the Presence of Cancer and Atrial Fibrillation: A Retrospective Study
10.3325/cmj.2024.65.405 · 2024 · External reference
Patient Characteristics Associated With Using Transcatheter Left Atrial Appendage Occlusion Versus Oral Anticoagulants for Atrial Fibrillation
2024 · External reference
Periprocedural Management of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Active Cancer
10.1016/j.jtha.2023.10.028 · 2024 · External reference
Selection of Rhythm Intervention Strategies in Atrial Fibrillation Patients With Cancer and Efficacy and Safety of Catheter Ablation
External reference
Atrial Fibrillation Management in Older Hospitalized Patients: Evidence of a Poor Oral Anticoagulants Prescriptive Attitude From the Italian REPOSI registry
10.1016/j.archger.2024.105602 · 2025 · External reference
CHA2DS2‐VASc Score in Patients With Atrial Fibrillation and Cancer: A U.S Nationwide Study
External reference
Clinical Predictors of Warfarin Response Among Patients With Atrial Fibrillation: Evidence From the Middle Eastern JoFib Study
10.2174/0115701611297687250221010411 · 2025 · External reference
Clustering of Electronic Health Records in Atrial Fibrillation Patients and Impact on Prognosis and Patient Trajectories: A UK Linked‐Dataset Study
10.1093/ehjdh/ztaf032 · 2025 · External reference
Correlation Between Anticoagulant Therapy Strategy and Bleeding Risk in Patients With Atrial Fibrillation Based on MIMIC‐ED database
External reference
Discriminative Accuracy of CHA2DS2‐VASc Score, and Development of Predictive Accuracy Model Using Machine Learning for Ischemic Stroke Risk in Cardiac Amyloidosis and Atrial Fibrillation
10.14740/cr2101 · 2025 · External reference
Early Rhythm Control of Atrial Fibrillation in Cancer Survivors: A Nationwide Population‐Based Study
10.1161/jaha.125.040908 · 2025 · External reference
Increasing Very Low‐Dose Edoxaban Prescription: Effectiveness and Safety Data of Korean AF Patients
10.4070/kcj.2024.0222 · 2025 · External reference
Long‐Term Prognosis in Early‐Onset Atrial Fibrillation Without Overt Cardiovascular Disease
2025 · External reference
Long‐Term Risks and Benefits of Oral Anticoagulation in Atrial Fibrillation Patients With Cancer: A Report From the GLORIA‐AF Registry
10.1111/eci.14347 · 2025 · External reference
Major Bleeding With Apixaban vs Aspirin: A Subanalysis of the ARTESiA Randomized Clinical Trial
10.1001/jamacardio.2025.4151 · 2025 · External reference
Phenotype‐Guided Risk Stratification in Anticoagulated Atrial Fibrillation Patients: Cluster Analysis of the Murcia AF Project III (MAFP‐III)
2025 · External reference
Post‐Discharge Pharmacotherapy in People With Atrial Fibrillation Hospitalized for Acute Myocardial Infarction: An Australian Cohort Study 2018‐22
10.1093/ehjqcco/qcae068 · 2025 · External reference
Short‐ and Long‐Term Outcomes of Percutaneous Left Atrial Appendage Occlusion in Cancer Patients
10.1016/j.ijcha.2024.101585 · 2025 · External reference
The Association of Malignancy With Stroke and Bleeding in Atrial Fibrillation: A Population‐Based Cohort Study
10.1016/j.jaccao.2024.10.014 · 2025 · External reference
Association of Warfarin Use With Lower Overall Cancer Incidence Among Patients Older Than 50 Years
10.1001/jamainternmed.2017.5512 · 2017 · External reference
The Associations of Atrial Fibrillation With the Risks of Incident Invasive Breast and Colorectal Cancer
10.1093/aje/kww185 · 2017 · External reference
Atrial Fibrillation and Risk of Cancer: A Danish Population‐Based Cohort Study
10.1161/jaha.118.009543 · 2018 · External reference
Efficacy and Safety of Edoxaban in Patients With Active Malignancy and Atrial Fibrillation: Analysis of the ENGAGE AF‐TIMI 48 Trial
10.1161/jaha.118.008987 · 2018 · External reference
The Association Between New Onset Atrial Fibrillation and Incident Cancer—A Nationwide Cohort Study
10.1371/journal.pone.0199901 · 2018 · External reference
Risk and Predictors of Subsequent Cancers of Patients With Newly‐Diagnosed Atrial Fibrillation—A Nationwide Population‐Based Study
10.1016/j.ijcard.2019.08.021 · 2019 · External reference
New Cancer Diagnosis After Bleeding in Anticoagulated Patients With Atrial Fibrillation
10.1161/jaha.120.016836 · 2020 · External reference
Risks and Outcomes of Gastrointestinal Malignancies in Anticoagulated Atrial Fibrillation Patients Experiencing Gastrointestinal Bleeding: A Nationwide Cohort Study
10.1016/j.hrthm.2020.05.026 · 2020 · External reference
The Association Between Oral Anticoagulants and Cancer Incidence Among Individuals With Nonvalvular Atrial Fibrillation
10.1055/s-0040-1714213 · 2020 · External reference
Association of Vitamin K and Non‐Vitamin K Oral Anticoagulant Use and Cancer Incidence in Atrial Fibrillation Patients
10.1002/cpt.2362 · 2022 · External reference
Anticoagulant‐Related Bleeding as a Sign of Underlying Tumoural Lesions in Patients With Atrial Fibrillation: A Nationwide Cohort Study
10.1093/ehjopen/oeae081 · 2024 · External reference
Direct Factor Xa Inhibitors and the Risk of Cancer and Cancer Mortality: A Danish Population‐Based Cohort Study
10.1371/journal.pmed.1004400 · 2024 · External reference
Bleeding and New Malignancy Diagnoses After Anticoagulation for Atrial Fibrillation: A Population‐Based Cohort Study
10.1161/circulationaha.124.070865 · 2025 · External reference
Cancer Incidence and Mortality Among Patients With New‐Onset Atrial Fibrillation: A Population‐Based Matched Cohort Study
10.1016/j.neo.2024.101080 · 2025 · External reference
Differences in Long Term Cancer Incidence and Overall Mortality Between Cardiovascular Diseases: A Nationwide Retrospective Health Insurance Claims Analysis
2025 · External reference
New‐Onset Atrial Fibrillation as a Predictor of Cancer: Insights From a Real‐World Dataset
2025 · External reference
Risk of Incident Genitourinary Cancer Following Hematuria in Patients With Atrial Fibrillation Receiving Oral Anticoagulants
10.1016/j.hrthm.2024.11.043 · 2025 · External reference
Associations Between Cancer and Atrial Fibrillation: The Atherosclerosis Risk in Communities Study
10.1016/j.mayocpiqo.2025.100634 · 2025 · External reference
Comparative Bleeding Risk in Patients With Atrial Fibrillation With Cancer Versus Without Cancer From Nationwide Prospective Cohort
10.1536/ihj.22-507 · 2023 · External reference
Safety of Catheter Ablation for Atrial Fibrillation in Patients With Cancer: A Nationwide Cohort Study
10.1080/00325481.2023.2218188 · 2023 · External reference
Cancer and Atrial Fibrillation: Epidemiology, Mechanisms, and Anticoagulation Treatment
10.1016/j.pcad.2021.04.004 · 2021 · External reference
Cancer Statistics, 2024
2024 · External reference
Cancer Incidence and Mortality According to Pre‐Existing Heart Failure in a Community‐Based Cohort
2022 · External reference
Association Between Heart Failure and the Incidence of Cancer: A Systematic Review and Meta‐Analysis
10.1093/ehjopen/oead073 · 2023 · External reference
Insights Into Onco‐Cardiology
10.1016/j.jacc.2013.11.026 · 2014 · External reference
The Mechanisms of Cancer‐Associated Thrombosis
10.1016/s0049-3848(15)50432-5 · 2015 · External reference
Cancer‐Associated Pathways and Biomarkers of Venous Thrombosis
10.1182/blood-2017-03-743211 · 2017 · External reference
Atrial Fibrillation and Mechanisms of Stroke: Time for a New Model
10.1161/strokeaha.115.012004 · 2016 · External reference
Atrial Fibrillation and Stroke Prevention: 25 Years of Research at EP Europace Journal
10.1093/europace/euad226 · 2023 · External reference
Oral Anticoagulants in Patients With Atrial Fibrillation and Active Cancer
10.31083/j.rcm2307242 · 2022 · External reference
Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: A Position Paper From the ESC Working Group on Thrombosis, in Collaboration With the European Heart Rhythm Association, the Association for Acute Cardiovascular Care and the Asia‐Pacific Heart Rhythm Society
10.1093/europace/euac020 · 2022 · External reference
The Anemia of Inflammation/Malignancy: Mechanisms and Management
10.1182/asheducation-2008.1.159 · 2008 · External reference
Causes of Death in Anticoagulated Patients With Atrial Fibrillation
10.1016/j.jacc.2016.09.944 · 2016 · External reference
Incidence, Risk Factors, and Mortality of Atrial Fibrillation in Breast Cancer: A SEER‐Medicare Analysis
10.1093/eurheartj/ehab745 · 2022 · External reference
Heterogeneity in Meta‐Analysis of Data From Epidemiologic Studies: A Commentary
10.1093/oxfordjournals.aje.a117644 · 1995 · External reference
Language Bias in Randomised Controlled Trials Published in English and German
10.1016/s0140-6736(97)02419-7 · 1997 · External reference
Including Papers in Languages Other Than English in Systematic Reviews: Important, Feasible, yet Often Omitted
10.1016/j.jclinepi.2019.03.004 · 2019 · External reference
Excluding Non‐English Publications From Evidence‐Syntheses Did Not Change Conclusions: A Meta‐Epidemiological Study
10.1016/j.jclinepi.2019.10.011 · 2020 · External reference
The Incidence of Esophageal Cancer and High‐Grade Dysplasia in Barrett's Esophagus: A Systematic Review and Meta‐Analysis
10.1093/aje/kwn121 · 2008 · External reference
Risk of Esophageal Adenocarcinoma and Mortality in Patients With Barrett's Esophagus: A Systematic Review and Meta‐Analysis
10.1016/j.cgh.2009.10.010 · 2010 · External reference
Incidence and Determinants of Hepatocellular Carcinoma in Autoimmune Hepatitis: A Systematic Review and Meta‐Analysis
10.1016/j.cgh.2017.02.006 · 2017 · External reference
Natural Regression of Frailty Among Community‐Dwelling Older Adults: A Systematic Review and Meta‐Analysis
10.1093/geront/gnz064 · 2020 · External reference
